AU1999301A - Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof - Google Patents

Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof

Info

Publication number
AU1999301A
AU1999301A AU19993/01A AU1999301A AU1999301A AU 1999301 A AU1999301 A AU 1999301A AU 19993/01 A AU19993/01 A AU 19993/01A AU 1999301 A AU1999301 A AU 1999301A AU 1999301 A AU1999301 A AU 1999301A
Authority
AU
Australia
Prior art keywords
theirproduction
derivatives
pharmacologically active
tetrahydro thiopyran
active tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19993/01A
Inventor
Shyam Sunder Chatterje
Klaus Klessing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Publication of AU1999301A publication Critical patent/AU1999301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
AU19993/01A 1999-11-12 2000-11-09 Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof Abandoned AU1999301A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19954569 1999-11-12
DE19954569A DE19954569A1 (en) 1999-11-12 1999-11-12 Pharmacologically active tetrahydrothiopyran-4-ol derivatives, process for their preparation and use
PCT/EP2000/011081 WO2001035938A2 (en) 1999-11-12 2000-11-09 Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for their production and use thereof

Publications (1)

Publication Number Publication Date
AU1999301A true AU1999301A (en) 2001-05-30

Family

ID=7928879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19993/01A Abandoned AU1999301A (en) 1999-11-12 2000-11-09 Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof

Country Status (3)

Country Link
AU (1) AU1999301A (en)
DE (1) DE19954569A1 (en)
WO (1) WO2001035938A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030017569A (en) 2000-06-28 2003-03-03 테바 파마슈티컬 인더스트리즈 리미티드 Carvedilol
JP2005515226A (en) 2002-01-15 2005-05-26 テバ ファーマシューティカル インダストリーズ リミティド Crystalline solids of carvedilol and methods for preparing them
EP1991527A2 (en) 2006-06-28 2008-11-19 Teva Pharmaceutical Industries Ltd Polymorphous forms of carvedilol phosphate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter

Also Published As

Publication number Publication date
DE19954569A1 (en) 2001-05-17
WO2001035938A2 (en) 2001-05-25
WO2001035938A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU7490200A (en) New and improved formulation for paclitaxel
AU6314900A (en) Biarylurea derivatives
AU7314200A (en) Benzimidazole derivatives
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU3076700A (en) 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
AU1302301A (en) Nitrogenous heterocycle derivatives
PL349863A1 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
AU1690100A (en) Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU5117400A (en) Tip structures, devices on their basis, and methods for their preparation
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
AU7318500A (en) Electrode structure, and rolling machine for working electrode structure
AU7952800A (en) 2-alkoxybenzene derivatives
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU6036100A (en) New pharmaceutically active compounds
AU1999301A (en) Pharmacologically active tetrahydro thiopyran-4-ol derivatives, method for theirproduction and use thereof
AU1887301A (en) Heterocycle derivatives and drugs
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU1347701A (en) Oxetanone derivatives
AU5974100A (en) 6-carboxyphenyldihydropyridazinone derivatives and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase